top of page
Search

What is the MHRA and What Do They Actually Do?

  • temidayodada
  • Oct 7, 2025
  • 2 min read

When I first stepped into the pharma world, MHRA was a word I kept seeing everywhere – press releases, packaging, LinkedIn posts, even in conversations that I quietly nodded through.


I had a rough idea that they “approve medicines”… but what does that actually mean? Who are they approving it for? And what happens after a drug gets approved?


This week I sat down, researched properly, and wrote this post to make it make sense – for me first, and for anyone else who’s learning like I am.


High angle view of a pharmaceutical warehouse filled with organized shelves of medication
A well-organized pharmaceutical warehouse ready for distribution.

So, what is the MHRA in plain English?


The MHRA is the Medicines and Healthcare products Regulatory Agency – basically the UK’s medicine safety authority.


If a medicine reaches a patient in the UK, it passed through them.


But here’s the part I didn’t realise until now: their job doesn’t stop at approval – it continues for the lifetime of that medicine.


What the MHRA actually does


Before a medicine is allowed in the UK:


✔ checks clinical data to see if it actually works

✔ reviews safety results from trials

✔ decides whether benefits outweigh risks

✔ gives the official licence if approved


Think of them like the examiner marking the final test paper for a new drug.


After it’s already on shelves:


✔ monitors side effects reports in real patients

✔ inspects manufacturers + wholesalers (GDP checks)

✔ investigates if something goes wrong

✔ can recall or suspend a drug any time


So approval isn’t a green light forever – more like a conditional pass based on good behaviour.


They also regulate:


✔ vaccines

✔ clinical trials

✔ medical devices

✔ blood & biological products


It’s bigger than I thought.


The drug approval process – using an analogy that helped me


The whole thing reminded me of getting a driving licence:

Drug Lifecycle

Driving Analogy

Drug discovery begins

Learning to drive

Early testing & research

Practising on quiet roads

Clinical trials (Phases 1–3)

Taking lessons + mock tests

Evidence submitted to MHRA

Booking the actual driving test

MHRA reviews and assesses

Examiner evaluates your skills

Approval granted

You pass your test

Pharmacovigilance continues

You still must obey the rules, or licence can be taken

Approval isn’t the end – it’s permission to continue under supervision. The medicine must still behave safely on the “road” (real-world patients).


What surprised me while learning this


  • Approval isn’t permanent – drugs can be recalled anytime

  • Wholesalers must comply with GDP standards under MHRA inspection

  • They regulate more than just medicines – devices, biologics, trials too


Final Thoughts


This post marks Day 1 of my journey documenting what I learn about pharmaceuticals in public. I’m not writing as an expert – I’m writing to become one, gradually, consistently, piece by piece.

If you’re learning too, follow along. We’ll figure this industry out together.

 
 
bottom of page